Form 8-K - Current report:
SEC Accession No. 0001564590-21-048250
Filing Date
2021-09-17
Accepted
2021-09-17 17:00:54
Documents
12
Period of Report
2021-09-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K txmd-8k_20210915.htm   iXBRL 8-K 31911
  Complete submission text file 0001564590-21-048250.txt   160680

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA txmd-20210915.xsd EX-101.SCH 5709
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20210915_lab.xml EX-101.LAB 19326
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20210915_pre.xml EX-101.PRE 11504
5 EXTRACTED XBRL INSTANCE DOCUMENT txmd-8k_20210915_htm.xml XML 3547
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 211261139
SIC: 2834 Pharmaceutical Preparations